Together, these assays recapitulate the growth disadvantage of CTSD-deficient tumor cells seen in the primary MMTV-cre;Ctsd−/− PyMT breast cancer model and provide evidence for tumor cell-autonomous functions of CTSD. This evidence concerns the gene CTSD and breast carcinoma.